Coherent Biopharma
Latest round
- Series B
Last raised
- May 2023
Total raised
- Undisclosed
Investors
- 14
About Coherent Biopharma
Established in 2016 and based in Suzhou, China, Coherent Biopharma, Ltd. is a dual-targeted ligand-coupled drug bi-XDC company dedicated to the development and industrialization of dual-targeted XDC drugs. The company's drug development center covers an area of 3600 square meters, management team includes two national major talent introduction project entrants and one high-level talent of Jiangsu Province for innovation and entrepreneurship. In 2020, The company's drugs CBP-1008, and CBP-1018 received US FDA clinical clearance and Chinese NMPA clinical trial standards. The company utilizes the BEST™ technology platform, the C-PROTAC technology platform, and the chronic disease technology platform for the development and industrialization of dual-targeted XDC drugs. Drug products include CBP-1008, a drug based on the first-generation bi-XDC technology platform, which is now in clinical phase I/II trials as a monotherapy regimen.
Who invested in Coherent Biopharma
14 investors across 4 rounds
See all investors in Coherent Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Coherent Biopharma
Who invested in Coherent Biopharma?
Coherent Biopharma has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Coherent Biopharma raised?
Coherent Biopharma has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Coherent Biopharma last raise money?
Coherent Biopharma's most recent round on record is a Series B, in May 2023.
What does Coherent Biopharma do?
Established in 2016 and based in Suzhou, China, Coherent Biopharma, Ltd.
Where is Coherent Biopharma headquartered?
Coherent Biopharma is headquartered in Suzhou, China.
Which VCs invest in companies like Coherent Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Coherent Biopharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Coherent Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.